Abliva

Delivering mitochondrial health

English
- English
- Svenska

Abliva
Mitochondrial Disease
Research & Development
Investors
News
Contact

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.

Abliva

Abliva develops medicines for the treatment of mitochondrial diseases. These congenital, rare and often very severe diseases occur when the cell's energy provider, the mitochondria, do not function properly. The portfolio includes projects at different stages and ranges from early discovery phase to clinical phase.

About us

Our board

The Board of Directors is the company’s highest administrative body subordinate to the AGM. The work of Abliva’s Board of Directors is regulated by applicable laws and ordinances, and by the Board of Directors’ rules of procedure, which are adopted annually.

Popular shortcuts

Research & Development

Investors

Primary mitochondrial disease

Interim reports

Receive updates straight to your inbox

Choose the categories that you are interested in, and check preferred language.

Startpage
News
Okategoriserade

This is Abliva

Strategy
Board
Team
Partners and advisers
Relevant publications

Research & Development

Research & Development
KL1333
NV354
Early programs
Partnering
BD Contact

Investors

Investors
Annual reports
Interim reports
Other financial information
Financial Calendar
Share and owner information
Equity research
Corporate governance
Current general meeting
General meetings archive
IR contact

News

Press releases
Newsletters
Events and Presentations
Capital Markets Day 2020
Mitochondria Day 2020
News subscription
Press photos
Media contact
Privacy policy

Contact

Abliva AB (publ)
Medicon Village
223 81 Lund, Sweden

Phone
+46 (0)46-275 62 20

Generel questions
info@abliva.com

We serve cookies. If you think that's ok, just click "Accept all". You can also choose what kind of cookies you want by clicking "Settings". Read our cookie policy

Settings Accept all

Choose what kind of cookies to accept. Your choice will be saved for one year. Read our cookie policy

Necessary
These cookies are not optional. They are needed for the website to function.
Statistics
In order for us to improve the website's functionality and structure, based on how the website is used.
Experience
In order for our website to perform as well as possible during your visit. If you refuse these cookies, some functionality will disappear from the website.
Marketing
By sharing your interests and behavior as you visit our site, you increase the chance of seeing personalized content and offers.

Save Accept all